
Technology and Scienceupdated 27m ago3 min read
Archive photo · 29 June 2014WHO Warns Antimicrobial Resistance Could Kill 39 Million Over 25 Years
3 Western Mainstream2 Other1 Asian1 West AsianPhoto: Sage Ross, CC BY-SA 3.0 · Cropped for layout
This article is an automated aggregation of coverage from news outlets. Our editorials offer in-depth analysis curated by the NewsCord team.
WHO warns antimicrobial resistance could cause 39 million deaths over 25 years. AMR could threaten routine surgery and childbirth worldwide.
Save coverage image
7 outlets in this story. Read their headlines below.
WHO warns of 39 million
The World Health Organization warned that growing antimicrobial resistance could cause 39 million deaths over the next 25 years, threatening routine surgery and childbirth. Jean-Pierre Nyemazi, acting director of the WHO’s AMR department, told a virtual conference of the 6th Annual Global Media Forum on AMR, "Antibiotic resistance – but broadly, we are talking about antimicrobial resistance, or AMR – is widespread and threatening the future of modern medicine,". WHO officials said progress in prevention, diagnosis and the appropriate use of antibiotics remained too slow to meet global targets, even as the agency said AMR was directly responsible for more than one million deaths in 2021 and linked to about 4.7 million others.
Pravasha Prakash, an AMR technical officer with the global health agency, said an investigation into the progress of the fight against antimicrobial resistance in 183 countries found that nearly nine in 10 had a national action plan, while only 42 countries had a plan that was financed, implemented and monitored. Sylvia Bertagnolo, head of surveillance for AMR at the WHO, said, "Without testing, clinicians must treat without knowing the cause of infection or which antibiotic will work."
Plans, labs, and new tools
WHO said its investigation into 183 countries found that nearly nine in 10 had a national action plan against antimicrobial resistance, but it said the 2017 figure was just about four in 10. Pravasha Prakash said only 42 countries, less than one in five, had a plan that was financed, implemented and monitored, and she added, "Countries are moving forward in every step, but progress still needs to be speeded up to reach the 2030 targets,". WHO said the latest global surveillance data showed that in 2023, one in every six laboratory-confirmed bacterial infections flagged to the WHO was resistant to antibiotics used to treat it.
The WHO announced the release of two new tools, with the first defining the tests that should be available at every level of the healthcare system and the second compiling 73 laboratory procedures from sample collection to identification of pathogens and antibiotic susceptibility testing. The WHO also said infection prevention, vaccination, improved access to water and sanitation, and the appropriate use of antimicrobials are the main levers to combat the issue.
What is at risk next
WHO warned that antimicrobial resistance threatens the future of modern medicine by making routine care life-threatening, and it said the problem jeopardizes surgical interventions, births, cancer treatments, transplants, and management of chronic diseases. Jean-Pierre Nyemazi said the pace of development often does not keep up with the rise of resistance, and he warned that investing in the responsible use of antimicrobials and researching new medicines "can save lives and generate economic benefits,". WHO said one of the main weaknesses in the fight against drug-resistant infections remains limited access to diagnostic testing, and it reported that only 36% of countries have a national reference laboratory capable of testing for resistance in all bacteria and fungi monitored by the WHO.
The WHO said it has estimated AMR could cause some 39 million deaths between now and 2050, and it linked the risk to the development of new medicines failing to keep pace with microorganisms developing resistance to existing treatments. The WHO said it is promoting the Global Action Plan on Antimicrobial Resistance 2026–2036, which sets targets to reduce deaths related to bacterial resistance and limit environmental contamination by resistant microorganisms and antimicrobial residues.